Global Preclinical CRO Market Analysis 2014-2017 with Forecasts to 2025 - Rise in the Number of Complex Drugs Entering Preclinical Trials

The global preclinical CRO market is anticipated to reach USD 6.6 billion by 2025.

The market is expected to witness lucrative growth during the forecast period owing to rise in R&D expenditure on early stage development as well as increase in number of drugs in preclinical phase. Hence, increase in outsourcing penetration is further expected to contribute to the growing demand of life science companies for outsourced preclinical services.

Rise in the number of complex drugs entering preclinical trial and growing pressure to curb R&D expenses are expected to contribute to the growing demand for quality CROs, thereby contributing to the market growth. As per Servier Research Institute, issues related to nonclinical toxicology testing results in a 50% failure rate in the early stage development phase. High failure rate in this phase is expected to contribute to the demand for early stage development CROs during the forecast period.

Rise in outsourcing of R&D and growing competency of CROs are expected to further contribute to the growing demand for early stage development CROs by life science companies. CRO's such as Charles River Laboratories and LabCorp specialize in early phase development services. Vendors in emerging countries, such as India and China, provide quick preclinical services at lower costs, which contributes to the outsourcing of R&D.

Further Key Findings From the Study Suggest:

Companies Mentioned

Key Topics Covered:

Chapter 1. Executive Summary
1.1. Market Snapshot

Chapter 2. Methodology and Scope
2.1. Information Procurement
2.2. Data Analysis
2.3. Market Formulation & Validation
2.4. Approaches for Market Estimation

Chapter 3. Preclinical CRO Market Variables, Trends & Scope
3.1. Market Segmentation & Scope
3.2. Market Driver Analysis
3.3. Penetration & Growth Prospect Mapping
3.4. SWOT Analysis, by Factor
3.5. Industry Analysis - Porter's

Chapter 4. Preclinical CRO: Service Estimates & Trend Analysis
4.1. Preclinical CRO Market Share, 2016 & 2025
4.2. Market Size, Estimates & Forecasts, and Trend Analyses, 2014 to 2025 for the following products:

Chapter 5. Preclinical CRO: End-Use Estimates & Trend Analysis
5.1. Preclinical CRO Market Share, 2016 & 2025
5.2. Market Size, Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following end users:

Chapter 6. Preclinical CRO: Regional Estimates & Trend Analysis
6.1. Preclinical CRO Regional Movement Analysis & Market Share, 2016 & 2025
6.2. North America
6.3. Europe
6.4. Asia Pacific
6.5. Latin America
6.6. MEA

Chapter 7. Competitive Landscape
7.1. Strategy Framework
7.2. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/xrzv3l/global?w=5

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716